Plasma pharmacokinetics and urinary excretion of the polyamine analogue 1,19-bis(ethylamino)-5,10,15-triazanonadecane in CD2F1 mice

Cancer Chemotherapy and Pharmacology

Volumn 38, Issue 1, 1996, Pages 13-20

  Eiseman, Julie L ^a,b   Yuan, Zhi Min ^a   Eddington, Natalie D ^c   Sentz, Dorothy L ^a   Callery, Patrick S ^c   Egorin, Merrill J ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

BE 4 4 4 4; Pharmacokinetics; Polymines

Indexed keywords

1,19 BIS(ETHYLAMINO) 5,10,15 TRIAZANONADECANE; BE 4 4 4 4; POLYAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BOLUS INJECTION; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG URINE LEVEL; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; URINARY EXCRETION;

ABSORPTION; ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HALF-LIFE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; LINEAR MODELS; MALE; MICE; PROTEIN BINDING; SPECIFIC PATHOGEN-FREE ORGANISMS; SPERMINE;

EID: 0029919337     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050441     Document Type: Article

References (20)

1. Akaike H (1979) A Bayesian extension of the minimal AIC procedures of autoregressive model fitting. Biometrika 66:237
2. Basu HS, Pellarin M, Feuerstein BG, Shirahata A, Samejima K, Deen DF, Marton LJ (1993) Interaction of the polyamine analogue. 1,19-bis-(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4), with DNA and effect on growth, survival and polyamine levels in seven human brain tumor cell lines. Cancer Res 53:3848
3. Bergeron CJ, Basu HS, Marton LJ, Deen DF, Pellarin M, Feuerstein BG (1995) Two polyamine analogs (BE-4-4-4 and BE-4-4-4-4) directly affect growth, survival, and cell cycle of human brain tumor cell lines U-251 MG and SF-767. Cancer Chemother Pharmacol 36:411
4. Cohen GM, Cullis PM, Hartley JA, Mather A, Symons MCR, Wheelhouse RT (1992) Targeting of cytotoxic agents by polyamines: synthesis of chlorambucil-spermidine conjugate. J Chem Soc Chem Commun 35:298
5. D'Argenio DZ, Schumitzky A (1979) A program package for simulation and parameter estimation in pharmacokinetic systems. Comput Methods Programs Biomed 9:115
6. Dolan ME, Fleig MJ, Feuerstein BG, Basu HS, Luk GD, Casero RA Jr, Marton LJ (1994) Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts. Cancer Res 54:4698
7. Edwards ML, Prakash NJ, Slemerick DM, Sunkara SP, Bitonti AJ, Davis GF, Dumont JA, Bey P (1990) Polyamine analogues with antitumor activity. J Med Chem 33:1369
8. Edwards ML, Snyder RD, Stemerick DM (1991) Synthesis and DNA-binding properties of polyamine analogs. J Med Chem 34:2414
9. Kabra PM, Lee HK (1986) Solid phase extraction and determination of dansyl derivatives of unconjugated and acetylated polyamines by reversed phase liquid chromatography: improved separation systems for polyamines in cerebrospinal fluid, urine and tissue. J Chromatogr 380:19
10. Lakanen JR, Coward JK, Pegg AE (1992) α-Methyl polyamines: metabolically stable spermidine and spermine mimics capable of supporting growth in cells depleted of polyamines. J Med Chem 35:724
11. Nagarajan S, Ganem B (1986) Chemistry of naturally occurring polyamines. 10. Nonmetabolizable derivatives of spermine and spermidine. J Org Chem 51:4856
12. Pegg AE (1988) Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48:759
13. 4-spermidine derivatives and their potential in anticancer activity. Cancer Res 42:4072
14. Porter CW, McManis J, Casero RA, Bergeron RJ (1987) Relative abilities of bis(ethyl)derivatives of putrescine, spermidine, and spermine to regulate polyamine biosynthesis and inhibit L1210 leukemia cell growth. Cancer Res 47:2821
15. Rinehart CA, Chen KY (1984) Characterization of the polyamine transport system in mouse neuroblastoma cells. Effect of sodium and system A amino acids. J Biol Chem 259:4750
16. Rocci ML, Jusko WJ (1983) LAGRAN program for area and moments in pharmacokinetic analysis. Comput Methods Programs Biomed 16:203
17. Shah VP, Midha KK, Dighe S, McGilvery IJ, Skelly, JP, Yacobi A, Layloff T, Viswanathan CE, Cook CE, McDowall RD, Pittman KA, Spector S (1991) Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Eur J Drug Metab Pharmacokinet 16:249
18. Stark PA, Thrall BD, Meadows GG, Abdel-Monem MM (1992) Synthesis and evaluation of novel spermidine derivatives as targeted cancer chemotherapeutic agents. J Med Chem 35:4264
19. Yeh KC, Kwan KC (1978) A comparison of numerical integrating algorithms by trapezoidal, LaGrange and Spline approximation. J Pharmacokinet Biopharm 6:79
20. 8-aziridinyl analogues of spermidine. Cancer Res 54:742